The site you are connecting to () is not published by YellowPages.ca™, so we cannot guarantee its availability or take responsibility for its content.
Do you wish to continue?
Filters
These guys are great. Sheldon said two weeks but it was completed a week ahead of time. Very friendly and professional. Thank You. Stewart
Read more
204-Project-Manufacturing near Springfield MB (10 Result(s))
Today's Power Transmission ChallengesMany challenges face power system engineers today. The traditional approach to planning transmission systems has now expanded to include new transmission options, options which can increase power transfers. For instance:AC LinesHigh Voltage Direct Current (HVDC)Voltage Source ConvertersShunt devices such as Static Compensators (STATCOMS) and Static VAR Compensators (SVCs)Integrating renewable energy sources such as off-shore or on-shore wind energy technology to existing grids, especially sources in remote locations, adds to the challenge.TransGrid Solutions can help you determine the optimal transmission options for your power system.Click here to download TGS' corporate brochure.TransGrid Solutions has the Knowledge and Tools to address these ChallengesUnderstanding the available transmission solutions, and then determining the optimum application, requires the expert application of sophisticated study tools including PSS/E, PSCAD/EMTDC and others.
PICCADILLY DECOROur HistoryAfter working in the graphic arts and trade show exhibit design industry for over two decades, Paul Martin founded Piccadilly Signs, with his wife Kelsey. Together they have over 35 years experience in the visual arts and sign fabricating field.Drawing from their extensive experience in painting, illustration, woodworking, carving and display manufacturing, they create hand-carved signs, built to their customers' specifications.Using their creativity, know-how and keen eye for detail, Paul and Kelsey create a unique piece of art with every completed project.
1441 Waverley St, Winnipeg, MB R3T 0P7
Metal Shearing, Heavy Equipment Repair, Parts Manufacturing, Industrial Parts, Custom Fabrication, CNC Plasma Cutting, Pipe Rolling, Pipe Notching, Rod Iron Work, Off Road Equipment Repair, Automotive Parts, Decorative Hand Rails, Pipe Bending, Metal Bending, Custom Welding, Recreational Parts
Custom Fabrication & Repair, Machine Work, Tube Bending, Welding of all metals, CNC Plasma Cutting, CNC Break and Shear
Saving Lives Through Early Disease DiagnosisMiraculins is an emerging biotechnology company committed to extending life, reducing suffering and lowering healthcare costs. Through our leadership in the development and commercialization of diagnostic tests, we strive to improve the overall diagnosis and treatment of patients by enhancing the information available to physicians.The Miraculins AdvantageProducts & ProgramsMiraculins is dedicated to the development and commercialization of diagnostic tests and risk assessment technologies for diseases and conditions that are lacking highly sensitive and specific tests.
Our ProductsAGGRASTAT® - US GP IIb/IIIa inhibitor market - $400 million (AGGRASTAT® + two competitors)TARDOXALTM - in Phase II clinical development for the treatment of Tardive Dyskinesia - a large, unmet needAbout MedicureMedicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics.HistoryMedicure founded in 1997 is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. Medicure has raised over $140 million and focused this investment on the advancement and clinical development of cardiovascular drugs. In 2006 Medicure acquired the USA commercial rights to AGGRASTAT (tirofiban HCl), a cardiovascular drug originally developed by Merck. AGGRASTAT, in combination with heparin, is indicated for the treatment of acute coronary syndrome. Medicurés business is generating revenue to support operations and to make selected investments in the clinical advancement of AGGRASTAT.TodayMedicurés core focus is on the US commercial sales of its FDA approved small molecule, AGGRASTAT.